Regeneron Pharmaceuticals Inc. buy knallfrosch44665
Start price
14.04.24
/
60%
€856.40
Target price
14.04.25
-
Performance (%)
-2.71%
Price
29.04.24
€833.20
Summary
This prediction is currently active. With a performance of -2.71%, the BUY prediction for Regeneron Pharmaceuticals Inc. by knallfrosch44665 is down slightly. This prediction currently runs until 14.04.25. The prediction end date can be changed by knallfrosch44665 at any time. knallfrosch44665 has 60% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Regeneron Pharmaceuticals Inc. | -1.396% |
| iShares Core DAX® | 0.961% |
| iShares Nasdaq 100 | 2.626% |
| iShares Nikkei 225® | 0.217% |
| iShares S&P 500 | 1.540% |
Comments by knallfrosch44665 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Buy Regeneron Pharmaceuticals Inc.